Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Neuroprotective agent described by Taisho

Jan. 16, 1997

Ortho reports analgesic drug candidates

Jan. 16, 1997

Johns Hopkins investigators report new growth factor

Jan. 16, 1997

SKB reports new delta-receptor agonists/antagonists

Jan. 16, 1997

New antimigraine agent from Pfizer

Jan. 15, 1997

Japanese scientists report cholecystokinin antagonists

Jan. 15, 1997

Second IND submitted for new ADHD therapy

Jan. 14, 1997

Subcutaneous BDNF not effective in ALS

Jan. 14, 1997

Neurogen reports CRF ligands for stress-related disorders

Jan. 14, 1997

Connective Therapeutics commences phase I/II of TCR vaccine for multiple sclerosis

Jan. 13, 1997

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...